Stockscreener 앱 받기
15.71
6.88%
-1.16
시간 외 거래:
15.71
전일 마감가:
$16.87
열려 있는:
$16.05
하루 거래량:
577.35K
Relative Volume:
1.49
시가총액:
$731.51M
수익:
$526.52M
순이익/손실:
$32.53M
주가수익비율:
23.32
EPS:
0.6738
순현금흐름:
$23.29M
1주 성능:
-3.56%
1개월 성능:
-10.59%
6개월 성능:
+25.78%
1년 성능:
+0.96%
1일 변동 폭
$15.45
$16.76
1주일 범위
$15.45
$17.07
52주 변동 폭
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Compare CLB vs SLB, BKR, HAL, TS, FTI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
15.71 | 785.52M | 526.52M | 32.53M | 23.29M | 0.6738 |
SLB
Slb Ltd
|
50.51 | 73.93B | 35.69B | 3.45B | 4.54B | 2.3617 |
BKR
Baker Hughes Company
|
63.49 | 61.79B | 27.73B | 2.62B | 2.54B | 2.605 |
HAL
Halliburton Co
|
38.11 | 31.42B | 22.18B | 1.29B | 1.67B | 1.5088 |
TS
Tenaris S A Adr
|
57.23 | 28.83B | 12.00B | 1.98B | 2.02B | 2.7949 |
FTI
Technipfmc Plc
|
70.16 | 27.20B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-06-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2023-04-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-10-07 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-09-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-07-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-11-11 | 재확인 | Cowen | Market Perform |
| 2020-10-13 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-09-29 | 업그레이드 | ABN Amro | Sell → Hold |
| 2020-07-16 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-01-31 | 재확인 | Cowen | Market Perform |
| 2020-01-30 | 재개 | Johnson Rice | Buy |
| 2020-01-14 | 개시 | Bernstein | Mkt Perform |
| 2020-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-12-31 | 재확인 | Cowen | Market Perform |
| 2019-07-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | 업그레이드 | Tudor Pickering | Hold → Buy |
| 2018-12-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2018-11-01 | 업그레이드 | ABN Amro | Sell → Buy |
| 2018-10-29 | 재확인 | Cowen | Market Perform |
모두보기
Core Laboratories Inc 주식(CLB)의 최신 뉴스
History Review: Is Core Laboratories Inc backed by strong institutional buying2026 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Gap DownHere's Why - MarketBeat
Here’s Why Maintaining a Hold Position Is Suitable for Core Laboratories Shares at This Time - Bitget
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - Yahoo Finance
Core Lab (CLB) Revises Q1 Revenue Forecast Amid Regional Challen - GuruFocus
Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict - Moomoo
Stocks to Watch: Core Laboratories, Bark - Moomoo
Core Laboratories (CLB) Shares Drop 4.7% After Lower Q1 Guidance - GuruFocus
Core Labs cuts Q1 guidance, citing impact of Middle East war (CLB:NYSE) - Seeking Alpha
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - Bitget
Core Laboratories cuts Q1 2026 guidance on Middle East conflict - Investing.com
Core Laboratories (CLB) Shares Fall 5% Following Preliminary Q1 Results - GuruFocus
Core Laboratories Cuts Q1 2026 Guidance Amid Mideast Turmoil - TipRanks
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07... - Benzinga
Core Laboratories Expects Q1 2026 Revenue An... - Benzinga
Core revises Q1 2026 guidance, now sees revenue $119M-$123M and EPS $0.05-$0.07 - TradingView
Core Laboratories Inc. Revises Earnings Guidance for the First Quarter 2026 - marketscreener.com
Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil - Stock Titan
Core Laboratories Inc. 2025 Annual Report – Business Overview, Strategy, Operations, and Climate Initiatives - Minichart
Core Laboratories 10-K: $526.5M Revenue, $0.65 Diluted EPS - TradingView
CWA Asset Management Group LLC Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (NYSE: CLB) outlines global operations, 2025 revenue and key risk exposures - Stock Titan
Core Laboratories Revises Financials Following Tax Review () - aktiencheck.de
Core Laboratories Inc. Files Form 8-K/A SEC Report for February 2026 – Company Information and Filing Details - Minichart
Core Laboratories (NYSE: CLB) trims 2025 EPS after $4.2M tax adjustment - Stock Titan
Core Laboratories Inc. $CLB Shares Sold by Earnest Partners LLC - MarketBeat
CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022 - Nasdaq
ProPetro (PUMP) Jumps 9.9%: Does the Stock Have More Room to Grow? - Bitget
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Total equity of Core Laboratories Inc. – DUS:HJ1 - TradingView
Core Laboratories Inc. Earnings and Revenue – DUS:HJ1 - TradingView
Quick ratio of Core Laboratories Inc. – DUS:HJ1 - TradingView
Debt to assets ratio of Core Laboratories Inc. – DUS:HJ1 - TradingView
Gross profit of Core Laboratories Inc. – DUS:HJ1 - TradingView
Core Laboratories Inc. (CLB) gains on sequential revenue growth and Solintec acquisition - MSN
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Will Core Laboratories Inc. stock benefit from upcoming earnings reportsMarket Weekly Review & Fast Moving Stock Trade Plans - Naître et grandir
Core Laboratories (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition - Insider Monkey
Why Is Core Laboratories (CLB) Down 14.2% Since Last Earnings Report? - Yahoo Finance
Core Laboratories Eases Shareholder Threshold for Major Deals - TipRanks
Royce & Associates LP Has $5.44 Million Holdings in Core Laboratories Inc. $CLB - MarketBeat
CLB SEC FilingsCore Laboratories Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Core Laboratories Delays 2025 Annual 10-K Filing - TipRanks
Core Laboratories (CLB) delays 2025 10-K amid international tax, control review - Stock Titan
CLB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Q1 EPS Forecast for Core Laboratories Lifted by Analyst - Defense World
Zacks Research Issues Optimistic Forecast for CLB Earnings - MarketBeat
CLB (Core Laboratories) ROC % : 5.95% (As of Dec. 2025) - GuruFocus
Core Laboratories (NYSE:CLB) Shares Surge Past Key Trend Line Nyse Composite Today - Kalkine Media
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Core Laboratories Inc (CLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
자본화:
|
볼륨(24시간):